News

Surplus Network Launches Tailored Surplus Liquidation Services For The Pharmaceutical And Biotechnology Sectors
Surplus Network Launches Tailored Surplus Liquidation Services for the Pharmaceutical and Biotechnology Sectors NEW YORK, NY, UNITED STATES ...
How did Emil Kakkis build Ultragenyx into an ultra-rare disease powerhouse?
From Washington to Wall Street, it's a crazy time for biotech. But as Ultragenyx Pharmaceutical Inc. celebrates its 15th ...
Driving Innovation in Biomedicine
With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...
Biotech business Atelerix signs distribution deal to expand into China
The firm has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organisation ...